Search

everythinglearnresearchcommunity

for

Search:↓

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

The conclusion suggests that the zinc lozenge study is valid despite imperfect blinding, as many participants could not correctly identify their lozenge type.

The European School of Oncology organized various educational events in 1994, highlighting important cancer research findings.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

Skin reactions from cancer treatments might predict how well the treatments work.

Genetics and nutritional deficiencies are key factors in premature graying of hair.

New mutations in MBTPS2 reduce its function and cause IFAP syndrome with unusual symptoms.

Retinoids are effective for various skin conditions and hair loss but have serious side effects, so low doses are recommended.

Phosphorylation controls TFEB's location in the cell, affecting cell metabolism and stress response.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Reductive stress messes up collagen balance and alters cell signaling in human skin cells, which could help treat certain skin diseases.

Many patients with various medical conditions experience anxiety, which worsens their quality of life and raises healthcare costs.

Cyclosporine-A can cause serious blood clots in the brain, so patients need careful monitoring.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

Drug repurposing speeds up development, cuts costs, and uses known safe drugs, but faces challenges like regulations and patents.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

Tinea capitis in adults, especially postmenopausal Black women, needs prompt treatment with oral antifungals to avoid scarring.